The global Tissue Diagnostic Market is expected to reach USD 5.02 Billion by 2027, according to a new report by Reports and Data. Tissue diagnostics is the process of removing the tissues and staining it for the diagnosis of diseases, particularly cancer. Recently, there have been novel technological advancements in the network-based medicine, which allows for detection, visualization, and monitoring of conditions in a more effective way, which would result in better treatment of the diseases.
The market is expanding as a result of the rising incidence of cancer. Global society, particularly US society, is significantly impacted by cancer. The likelihood of survival is considerably increased by early cancer detection. The key measures in early cancer detection are raising awareness to promote early diagnosis and screening. For an early diagnosis of cancer, recognising the warning signs and acting quickly are essential. Increased knowledge of potential cancer signs among doctors, nurses, and other healthcare professionals, as well as the general public, would improve the survival rate and hence play a key role in driving up market demand.
Request Free Sample Copy @ https://www.reportsanddata.com/download-free-sample/3411
Further key findings from the report suggest
- By type, diagnostics kits held a substantial market share in 2019, owing to the offering of ease and convenience of use. There are various diagnostic kits available in the market, some of which provide an instant result, whereas others as collection devices for tissue specimens, which need to be sent to laboratories for further processing.
- By technology, in situ hybridization held the second-largest market share in 2019. There are many advantages of in situ hybridization comprising the application to frozen tissues, as well as its usage in combination with immunohistochemistry for the identification protein, along with mRNA.
- By application, prostate cancer is likely to grow at a rate of 5.9% in the forecast period. According to the American Cancer Society, men aged 65 years or older have around 66.0% higher risk of suffering from the disease. Also, prostate cancer holds the second spot among the cancer diseases responsible for the death of men in America.
- By end-user, the pharmaceutical organization is likely to grow at a rate of 6.5% in the forecast period 2019, owing to an extensive application of tissue diagnostic in the process of drug development and several other analytical procedures.
- The market in the Asia Pacific region is expected to grow at the fastest rate of 7.3% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in RD activities the diagnostic procedures, among others.
Competitive Outlook of the Global Tissue Diagnostics Market
The globla Tissue Diagnostics market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Tissue Diagnostics market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.
Top Companies Profiled in the Report:
Thermo Fisher Scientific, Danaher, Becton, Dickinson, and Company, Agilent Technologies, Abbott, Roche, Merck KGaA, Biogenex, Hologic Inc., and Abcam, among others.
Tissue Diagnostics Market Segmentation:
Type Outlook (Revenue, USD Million; 2017-2027)
- Diagnostic Kits
- Antibodies
- Slide Training System
- Tissue Processing System
Technology Outlook (Revenue, USD Million; 2017-2027)
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology Workflow
- Primary Special Training
- Anatomic Pathology
Application Outlook (Revenue, USD Million; 2017-2027)
- Breast Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Lung Cancer
- Others
End-User Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Research Laboratories
- Pharmaceutical Organizations
- Contract Research Organizations
Geographic Segment Covered in the Report:
The Tissue Diagnostics report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
- North America (USA and Canada)
- Europe (UK, Germany, France and the rest of Europe)
- Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
- Latin America (Brazil, Mexico, and the rest of Latin America)
- Middle East and Africa (GCC and rest of the Middle East and Africa)
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3411
We appreciate you reading our report. To learn more about the report and its customizable feature, please get in touch with us. Our team will make sure the report is suitable for your needs.
Get Explore Latest Research Report by Reports and Data:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian